These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7070229)

  • 21. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 microliter plasma.
    Hunneman DH
    Clin Chim Acta; 1983 Dec; 135(2):169-74. PubMed ID: 6652925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morning variations of plasma homovanillic acid in untreated schizophrenic patients.
    Zumárraga M; Andía I; Bárcena B; González-Torres MA; Dávila R
    J Psychiatr Res; 1993; 27(1):11-6. PubMed ID: 8515382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of 3-methoxy-4-hydroxyphenylacetic acid (HVA) in plasma by high-performance liquid chromatography with electrochemical detector (HPLC-EC).
    Javaid JI; Liu TS; Maas JW; Davis JM
    Anal Biochem; 1983 Dec; 135(2):326-31. PubMed ID: 6197905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M; Losonczy MF; Mohs RC; Lesser JC; Powchik P; Freed LB; Davis BM; Mykytyn VV; Davis KL
    Neuropsychopharmacology; 1987 Dec; 1(1):17-23. PubMed ID: 3509064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerance to stereotyped behaviour and to decrease in striatal homovanillic acid levels after repeated treatment with apomorphine dipivaloyl ester.
    Worms P; Scatton B
    Eur J Pharmacol; 1977 Oct; 45(4):395-6. PubMed ID: 562764
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites.
    Diggory GL; Buckett WR
    Eur J Pharmacol; 1984 Oct; 105(3-4):257-63. PubMed ID: 6510470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute administration of alprazolam has no effect on plasma homovanillic acid concentration in normal subjects.
    Zemishlany Z; Davidson M; Jaff S; McQueeney R
    Schizophr Res; 1991; 5(1):81-3. PubMed ID: 1677266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
    Davila R; Zumarraga M; Andia I; Friedhoff AJ
    Life Sci; 1989; 44(16):1117-21. PubMed ID: 2565009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of plasma homovanillic acid as an index of brain dopamine function.
    Kendler KS; Hsieh JY; Davis KL
    Psychopharmacol Bull; 1982 Oct; 18(4):152-5. PubMed ID: 7156280
    [No Abstract]   [Full Text] [Related]  

  • 31. Routine measurement of homovanillic acid in rat brain by gas-liquid chromatography.
    Walter DS; Dettmar PW; Taylor K; Shilcock GM; Cowan A
    J Neurochem; 1978 Apr; 30(4):929-31. PubMed ID: 650236
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of diet and physical activity on plasma homovanillic acid in normal human subjects.
    Kendler KS; Mohs RC; Davis KL
    Psychiatry Res; 1983 Mar; 8(3):215-23. PubMed ID: 6574541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement.
    Nibuya M; Kanba S; Sekiya U; Suzuki E; Matsuo Y; Kinoshita N; Shintani F; Yagi G; Asai M
    Biol Psychiatry; 1995 Jul; 38(1):50-6. PubMed ID: 7548472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of piribedil and one of its metabolites on the concentration of homovanillic acid in the rat brain.
    Jori A; Cecchetti G; Dolfini E; Monti E; Garattini S
    Eur J Pharmacol; 1974 Jul; 27(2):245-8. PubMed ID: 4851685
    [No Abstract]   [Full Text] [Related]  

  • 35. Highly sensitive method for the quantitation of homovanillic acid in cerebrospinal fluid.
    Vogt W; Jacob K; Ohnesorge AB; Schwertfeger G
    J Chromatogr; 1980 Oct; 199():191-7. PubMed ID: 7451601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma homovanillic acid in schizophrenics: supportive evidence for the two-subtype hypothesis.
    Chen TY; Lee CF; Lung FW; Lee TC; Lin WL; Hu WH; Yeh EK; Chang WH
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):584-8. PubMed ID: 2571672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity.
    Bacopoulos NG; Hattox SE; Roth RH
    Eur J Pharmacol; 1979 Jun; 56(3):225-36. PubMed ID: 477719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
    Hollander E; Nunes E; DeCaria CM; Quitkin FM; Cooper T; Wager S; Klein DF
    Psychiatry Res; 1990 Aug; 33(2):161-9. PubMed ID: 2243893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schizophrenia: gender, family risk, and plasma homovanillic acid.
    Dávila R; Zumárraga M; González-Torres MA; Andía I; Zamalloa MI; Basterreche E; Guimón J; Friedhoff AJ
    Am J Med Genet; 1995 Apr; 60(2):154-6. PubMed ID: 7485251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by apomorphine of dopamine deamination in the rat brain.
    Di Chiara G; Balakleevsky A; Porceddu ML; Tagliamonte A; Gessa GL
    J Neurochem; 1974 Dec; 23(6):1105-8. PubMed ID: 4452897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.